WLLW Stock Overview
A biotechnology company, develops, produces, and sells plant derived ingredients for consumer care, food and beverage, and pharmaceutical products in the United States. More details
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
Willow Biosciences Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CA$0.095 |
| 52 Week High | CA$0.15 |
| 52 Week Low | CA$0.07 |
| Beta | 1.14 |
| 11 Month Change | 5.56% |
| 3 Month Change | 0% |
| 1 Year Change | 35.71% |
| 33 Year Change | -79.79% |
| 5 Year Change | -85.61% |
| Change since IPO | -96.83% |
Recent News & Updates
Recent updates
Is Willow Biosciences (TSE:WLLW) In A Good Position To Deliver On Growth Plans?
Apr 11
We Think Willow Biosciences (TSE:WLLW) Needs To Drive Business Growth Carefully
Dec 20We Think Willow Biosciences (TSE:WLLW) Can Afford To Drive Business Growth
Sep 02We Think Willow Biosciences (TSE:WLLW) Can Easily Afford To Drive Business Growth
May 20Calculating The Fair Value Of Willow Biosciences Inc. (TSE:WLLW)
Jan 19Shareholder Returns
| WLLW | CA Biotechs | CA Market | |
|---|---|---|---|
| 7D | 11.8% | -13.2% | -0.7% |
| 1Y | 35.7% | -8.5% | 20.2% |
Return vs Industry: WLLW exceeded the Canadian Biotechs industry which returned -8.5% over the past year.
Return vs Market: WLLW underperformed the Canadian Market which returned 20.2% over the past year.
Price Volatility
| WLLW volatility | |
|---|---|
| WLLW Average Weekly Movement | 9.9% |
| Biotechs Industry Average Movement | 11.3% |
| Market Average Movement | 8.3% |
| 10% most volatile stocks in CA Market | 17.5% |
| 10% least volatile stocks in CA Market | 2.9% |
Stable Share Price: WLLW has not had significant price volatility in the past 3 months compared to the Canadian market.
Volatility Over Time: WLLW's weekly volatility (10%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2019 | 19 | Chris Savile | www.willowbio.com |
Willow Biosciences Inc., a biotechnology company, develops, produces, and sells plant derived ingredients for consumer care, food and beverage, and pharmaceutical products in the United States. The company has a collaboration agreement with SUANFARMA to develop anti-infective API through precision fermentation; and a multi-product development and licensing partnership with Laurus Labs for manufacturing active pharmaceutical ingredients. Willow Biosciences Inc. was founded in 2019 and is headquartered in Calgary, Canada.
Willow Biosciences Inc. Fundamentals Summary
| WLLW fundamental statistics | |
|---|---|
| Market cap | CA$13.70m |
| Earnings (TTM) | -CA$7.71m |
| Revenue (TTM) | CA$2.87m |
4.8x
P/S Ratio-1.8x
P/E RatioIs WLLW overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| WLLW income statement (TTM) | |
|---|---|
| Revenue | CA$2.87m |
| Cost of Revenue | CA$1.18m |
| Gross Profit | CA$1.69m |
| Other Expenses | CA$9.41m |
| Earnings | -CA$7.71m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.054 |
| Gross Margin | 58.91% |
| Net Profit Margin | -268.91% |
| Debt/Equity Ratio | 361.0% |
How did WLLW perform over the long term?
See historical performance and comparison